Legal & General Group
ZYME icon

Legal & General Group’s Zymeworks ZYME Stock Holding History

Legal & General Group’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.13M Buy
43,160
+16,951
+65% +$431K ﹤0.01% 2159
2026
Q1 		$656K Sell
26,209
-5,940
-18% -$141K ﹤0.01% 2283
2025
Q4 		$846K Buy
32,149
+3,780
+13% +$82.4K ﹤0.01% 2266
2025
Q3 		$485K Sell
28,369
-15,394
-35% -$220K ﹤0.01% 2455
2025
Q2 		$549K Sell
43,763
-3,027
-6% -$36.1K ﹤0.01% 2417
2025
Q1 		$557K Sell
46,790
-292
-0.6% -$3.98K ﹤0.01% 2366
2024
Q4 		$689K Buy
47,082
+7,511
+19% +$105K ﹤0.01% 2353
2024
Q3 		$497K Buy
39,571
+4,031
+11% +$43.9K ﹤0.01% 2459
2024
Q2 		$302K Sell
35,540
-4,398
-11% -$39.1K ﹤0.01% 2600
2024
Q1 		$418K Sell
39,938
-270
-0.7% -$3K ﹤0.01% 2498
2023
Q4 		$418K Buy
40,208
+3,934
+11% +$31.4K ﹤0.01% 2526
2023
Q3 		$230K Sell
36,274
-3,942
-10% -$29.1K ﹤0.01% 2694
2023
Q2 		$347K Buy
40,216
+20,854
+108% +$187K ﹤0.01% 2577
2023
Q1 		$175K Buy
+19,362
New +$169K ﹤0.01% 2631
2022
Q2 		– Sell
-17,070
Closed -$112K – 3678
2022
Q1 		$112K Buy
17,070
+2,500
+17% +$22.3K ﹤0.01% 2837
2021
Q4 		$239K Buy
14,570
+5,815
+66% +$121K ﹤0.01% 2650
2021
Q3 		$254K Buy
8,755
+7,295
+500% +$243K ﹤0.01% 2610
2021
Q2 		$51K Hold
1,460
– – ﹤0.01% 2946
2021
Q1 		$46K Hold
1,460
– – ﹤0.01% 2839
2020
Q4 		$69K Hold
1,460
– – ﹤0.01% 2702
2020
Q3 		$68K Hold
1,460
– – ﹤0.01% 2595
2020
Q2 		$53K Buy
+1,460
New +$53.8K ﹤0.01% 2712

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Legal & General Group's ZYME Position: Q2 2026 in Review

Legal & General Group increased its Zymeworks (ZYME) stake by 65% in Q2 2026, buying an estimated $431K and bringing the position to 43,160 shares worth $1.13M. The position accounts for ﹤0.01% of the portfolio, ranked #2159.

Legal & General Group first reported a position in ZYME in Q2 2020 and has held it in 22 quarters since. 202 funds tracked by Wall St. Rank hold ZYME as of Q2 2026.

  • Legal & General Group held 43,160 shares of Zymeworks worth $1.13M as of Q2 2026.
  • Legal & General Group bought 16,951 Zymeworks shares in Q2 2026, an estimated $431K.
  • Zymeworks made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #2159 holding.
  • Legal & General Group first reported a position in Zymeworks in Q2 2020 and has held it in 22 quarters since.
  • 202 funds tracked by Wall St. Rank held Zymeworks as of Q2 2026.

Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.